parp inhibitors and immunotherapy in ovarian cancer: from research to practice
Published 4 years ago • 182 plays • Length 8:53Download video MP4
Download video MP3
Similar videos
-
2:38
assessing the role of parp inhibitors and immunotherapy in ovarian cancer
-
31:13
parp inhibitors and immunotherapy - dr yvette drew
-
1:38
updates in parp inhibition for ovarian cancer
-
1:22
overcoming resistance to parp inhibition in ovarian cancer
-
2:16
biomarker for parp inhibitor responsiveness in ovarian cancer patients
-
57:11
personalizing advanced ovarian cancer treatment with parp inhibitors and novel approaches
-
59:14
parp inhibitors in ovarian cancer: clinical updates from sgo 2023
-
8:44
parp inhibition in ovarian cancer
-
39:11
new treatment approaches for ovarian cancer parp inhibitors hipec and immunotherapy
-
1:53
parp inhibitors: game-changers for ovarian cancer patients?
-
3:52
benefits and challenges of using parp inhibitors to treat metastatic breast cancer
-
6:25
combinations with parp inhibitors for ovarian cancer
-
2:02
dr. konecny on resistance to parp inhibitors in ovarian cancer
-
59:02
parp inhibitors as first-line maintenance therapy in ovarian cancer
-
1:27
parp inhibition improves outcomes in patients with brca-mutated ovarian cancer
-
1:27
how parp inhibitors can increase response to immunotherapy
-
1:29:06
the advanced ovarian cancer treatment palette: candid conversations on parp inhibitors
-
1:45
dr patricia roxburgh: can resistance to parp inhibitors be overcome in advanced ovarian cancers?
-
2:30
do icis with parp inhibitors have a role in treating ovarian cancer?